Body Composition Changes with Long-term Pegvisomant Therapy of Acromegaly

CONTEXT: In active acromegaly, the lipolytic and insulin antagonistic effects of growth hormone (GH) excess alter adipose tissue (AT) deposition, reduce body fat, and increase insulin resistance. This pattern reverses with surgical therapy. Pegvisomant treats acromegaly by blocking GH receptor (GHR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuker, Adriana P, Shen, Wei, Jin, Zhezhen, Singh, Simran, Chen, Jun, Bruce, Jeffrey N, Freda, Pamela U
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853172/
https://www.ncbi.nlm.nih.gov/pubmed/33553983
http://dx.doi.org/10.1210/jendso/bvab004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853172/
https://www.ncbi.nlm.nih.gov/pubmed/33553983
http://dx.doi.org/10.1210/jendso/bvab004

Ejemplares similares